glp 1 crackdown Despite FDA crackdown, unapproved GLP-1s still threaten the industry The FDA's GLP-1 Compounding Crackdown

Gina: Oh

A: No, not in the cream form

Despite its weight loss benefits, it is not officially approved by the FDA as a weight loss drug

Diabetic Peripheral Neuropathy: A Clinicopathologic and Immunohistochemical Analysis of Sural Nerve Biopsies

Finally, we thank our funding sources: Genome Canada and Genome BC (275SIL and 298SGC), Canadian Institutes of Health Research (GP1-155868), BC Childrens Hospital Research Institute and BC Childrens Hospital Foundation, Illumina (in-kind), Provincial Health Services Authority, Alberta Children's Hospital Foundation and Canadian Rare Diseases: Models & Mechanisms Network (RDMM)